Effect of eribulin on patients with metastatic breast cancer: multicenter retrospective observational study in Taiwan.
Kun-Ming RauFu Ou-YangTa-Chung ChaoYao-Lung KuoTsui-Fen ChengTsu-Yi ChaoDar-Ren ChenYen-Dun TzengBeing-Whey WangChun-Yu LiuMing-Hung HuYin-Che LuWei-Jen OuChin-Ho KuoChieh-Han ChuangJung-Yu KanFang-Ming ChenMing-Feng HouPublished in: Breast cancer research and treatment (2018)
Eribulin appears to have better efficacy and cause fewer adverse events, especially neutropenia, in Taiwanese women than Western women.